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We previously linked Laing-type early-onset autosomal dominant distal myopathy (MPD1) to a 22-cM region of
chromosome 14. One candidate gene in the region, MYH7, which is mutated in cardiomyopathy and myosin storage
myopathy, codes for the myosin heavy chain of type I skeletal muscle ﬁbers and cardiac ventricles. We have identiﬁed
ﬁve novel heterozygous mutations—Arg1500Pro, Lys1617del, Ala1663Pro, Leu1706Pro, and Lys1729del in exons
32, 34, 35, and 36 of MYH7—in six families with early-onset distal myopathy. All ﬁve mutations are predicted,
by in silico analysis, to locally disrupt the ability of the myosin tail to form the coiled coil, which is its normal
structure. These ﬁndings demonstrate that heterozygous mutations toward the 3′ end of MYH7 cause Laing-type
early-onset distal myopathy. MYH7 is the fourth distal-myopathy gene to have been identiﬁed.
The distal myopathies form a group of disorders that is
heterogeneous both clinically and genetically. They are
characterized by weakness starting in the anterior or
posterior compartment of either the distal upper or the
distal lower limb and show either autosomal dominant
or autosomal recessive inheritance. (For recent reviews,
see Udd and Griggs [2001] and Udd et al. [2002]). To
date, the genes for three distal myopathies have been
identiﬁed: dysferlin, in Miyoshi myopathy (Bashir et al.
1998; Liu et al. 1998); titin, in tibial muscular dystrophy
(Hackman et al. 2002); and UDP-N-acetylglucosamine
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2-epimerase/N-acetylmannosamine kinase (GNE), in
Nonaka myopathy (Kayashima et al. 2002; Nishino et
al. 2002). Proteins mutated in other muscle diseases may
also cause distal phenotypes (Sjoberg et al. 1999; Ta-
teyama et al. 2002). Other distal myopathies have been
linked to loci, but the genes have not been identiﬁed.
These include Welander distal myopathy (Ahlberg et al.
1999); Miyoshi myopathy, for which a second locus has
been linked to chromosome 10 (Linssen et al. 1998);
distal myopathy with vocal cord and pharyngeal weak-
ness (Feit et al. 1998); and a unique distal myopathy
(MPD3) in a Finnish family (Haravuori et al. 2004). A
number of other distal myopathies remain unlinked (Fel-
ice et al. 1999; Udd et al. 2002).
Laing-type early-onset distal myopathy (MPD1 [MIM
160500]) is phenotypically different from other domi-
nant distal myopathies in showing onset as early as age
4 years (range 4–25 years). Selective weakness of the
anterior tibial muscles is followed by weakness of the
ﬁnger extensors and of selected proximal muscle groups,
such as the hip abductors and rotators, the shoulder
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Table 1
Families and Heterozygous Mutations Identiﬁed in the Present Study
Family Reference Mutation Exon
1 Laing et al. 1995 c.A1663P 35
2 Voit et al. 2001 c.K1617del 34
3 Zimprich et al. 2000 c.K1617del 34
4 Present study c.L1706P 35
5 Hedera et al. 2003 c.K1729del 36
6 Present study c.R1500P 32
7 Scoppetta et al. 1995 None identiﬁed …
abductors, and the sternocleidomastoids in some pa-
tients (Laing et al. 1995; Voit et al. 2001; Mastaglia et
al. 2002; Hedera et al. 2003). We linked Laing-type dis-
tal myopathy to chromosome 14, in 1995 (Laing et al.
1995). Smaller European families with similar pheno-
types showed evidence of linkage to the same locus (Voit
et al. 2001), and a large U.S. family showed linkage to
the locus (Hedera et al. 2003). A recombination in an
unaffected individual in the U.S. family made it possible
to reduce the linkage region to a still-large 22 cM (Hed-
era et al. 2003). A positional candidate gene approach
(Collins 1995) was therefore the only possible course for
identifying the disease gene. Within the linkage region
is the gene, MYH7, for the slow skeletal muscle ﬁber
myosin heavy chain, which is also expressed in cardiac
muscle (Lompre et al. 1984). Mutations in MYH7 cause
dilated and hypertrophic cardiomyopathy (Geisterfer-
Lowrance et al. 1990; Seidman and Seidman 2001; Rich-
ard et al. 2003) and the skeletal muscle disease myosin
storage myopathy (hyaline body myopathy) (Tajsharghi
et al. 2003; Bohlega et al. 2004). We investigatedMYH7
as a candidate gene for Laing-type distal myopathy in
seven separate families.
We identiﬁed heterozygous mutations in the light mer-
omyosin (LMM) region of the MYH7 tail in six of the
seven families (table 1). We identiﬁed the mutation in
family 1 by sequencing the entire coding region of
MYH7 from cDNA. The other mutations were identiﬁed
from genomic DNA by ampliﬁcation and sequencing of
all 40 MYH7 exons. The mutations identiﬁed in families
1–4 were not seen in 400 control chromosomes, and the
mutations in families 5 and 6 were not seen in 200 con-
trol chromosomes. The mutations identiﬁed in the fam-
ilies showing dominant inheritance (families 1, 2, 3, and
5) segregated with the disease, resulting in a combined
LOD score of 8.7 at a recombination fraction of 0.
Families 4 and 6 consist of previously unpublished
isolated patients from the Netherlands andWesternAus-
tralia who received diagnoses (from M.d.V. and P.L.) of
Laing myopathy based on the published descriptions of
the disease (Laing et al. 1995; Voit et al. 2001;Mastaglia
et al. 2002). The Dutch patient is a 32-year-old woman
who has had bilateral foot drop since the age of 5 years
and slowly progressive proximal weakness since the age
of 6 years. She also has severe weakness and atrophy of
the sternocleidomastoid muscles and a rigid neck. The
Western Australian patient, from family 6, was noted at
birth to have mild talipes equinovarus, but this corrected
itself. Early motor milestones were appropriate in this
patient, but, by the time she was 4 years old, she was
noted to have weakness of ankle dorsiﬂexion that was
more severe on the right side than on the left. Since then,
she has had slowly progressive weakness of her legs and
hands. Her arms started to become weak at 11 years of
age. Intellectually, she is an excellent student. On ex-
amination, there was mild facial weakness, but she had
full external ocular movements and no ptosis. The pa-
tient had a Trendelenburg gait, foot drop, mild scapular
winging, and ﬂexion contractures of the ﬁngers. There
was generalized limb weakness, in the legs more than in
the arms. There was marked weakness of the sterno-
cleidomastoid muscles bilaterally. Other axial muscles
were strong. Deep tendon reﬂexes were present but
markedly reduced. Results of cardiac examination, cre-
atine kinase tests, and nerve conduction studies were
normal.
The c.R1500P and c.L1706P mutations identiﬁed in
the isolated patients in families 4 and 6 were not present
in either parent, whereas paternity/maternity was con-
sistent in analysis of multiple microsatellites. The mu-
tations are thus de novo mutations arising in the pedi-
grees at the same point as the disease.
Family 7 is an Italian family with early-onset distal
myopathy (Scoppetta et al. 1995). Sequencing all 40
MYH7 exons did not result in identiﬁcation of a mu-
tation, despite the family showing evidence of linkage
to the MYH7 region (Voit et al. 2001).
Family 2 from Germany and family 3 from Austria
have the same c.K1617del mutation. It is possible, there-
fore, that the two families share a founder mutation.
However, haplotype analysis (table 2) gives no indication
that the families share a disease haplotype, suggesting
that the same mutation has probably arisen indepen-
dently in the two families.
MYH7 codes for the isoform ofmyosin present in slow
(type I) skeletal muscle ﬁbers. Consistent with this, the
commonest ﬁndings on muscle biopsy, present in four
families, were atrophy and grouping of type I muscle
ﬁbers (ﬁg. 1A). In some patients, the numbers of type I
ﬁbers were depleted. However, there was considerable
variability in the severity of pathological changes in af-
fected individuals. Nonspeciﬁc myopathic changes, in-
cluding excessive variation in ﬁber size, central nuclea-
tion, ﬁber splitting, “moth-eaten” ﬁbers, and ring ﬁbers,
were present to variable degrees in different families. In
the biopsy specimens from older patients, there were
secondary effects in type II ﬁbers (ﬁg. 1B). In the biopsy
specimen from one patient (family 4), muscle ﬁber vac-
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Table 2
















D14S1003 13.4 20106473–20106637 167 165
D14S283 14.7 20677673–20677803 136 145
D14S990 15.4 21576515–21576761 147 155
MYH7 … 21872077–21894978 … …
D14S581 18.5 22288637–22288827 192 196
D14S972 18.5 22337862–22338070 206 204
D14S264 19.6 23270071–23270286 226 228
a From the University of California Santa Cruz Genome Bioinfor-
matics Web site.
Figure 1 Sections stained for myosin ATPase (pH 9.4) from
vastus lateralis biopsies in the probands from family 6 (age 12 years)
(A) and family 1 (age 48 years) (B). In the section shown in panel A,
there is selective atrophy of the type I ﬁbers (lightly stained). In the
section shown in panel B, there is atrophy and angulation, mainly of
type I ﬁbers, but type II ﬁbers are also occasionally atrophic. Mag-
niﬁcations: A, #400; B, #160.
uolation and necrosis were present in both ﬁber types.
The muscle pathology is, thus, pleomorphic.
We have therefore identiﬁed ﬁve mutations in exons
32, 34, 35, and 36 of MYH7 in six families with Laing
distal myopathy. The pathophysiology of the mutations
is unclear. Three of the mutations introduce proline,
whereas the other two are deletions of single amino ac-
ids. The myosin tail forms the coiled coil that is the basis
of the myosin dimerization and the structure of the thick
ﬁlament (McLachlan and Karn 1982; Craig 1994). Pro-
lines are incompatible with coiled coils (O’Neil and
DeGrado 1990) (there are normally no prolines in the
myosin rod [McLachlan and Karn 1982]), whereas de-
letion of a single amino acid disrupts the heptad repeat
essential to the formation of a coiled coil (O’Neil and
DeGrado 1990). The effects of the ﬁve Laing myopathy
mutations and of the LMM hypertrophic cardiomyop-
athy mutations (Blair et al. 2002; Richard et al. 2003)
on the coiled coil structure of myosin were analyzed
using the COILS program (Lupas et al. 1991). The prob-
ability of coiled coil formation was predicted for each
mutation and compared with the predicted probability
for the normal protein sequence. Probabilities were cal-
culated using the MTK (myosin, tropomyosin, and ker-
atin) matrix with amino acid window lengths of 14, 21,
and 28. All ﬁve Laing myopathy mutations signiﬁcantly
decreased the probability of coiled coil formation over
segments of the myosin tail (ﬁg. 2A). However, the LMM
hypertrophic cardiomyopathy mutations had no signif-
icant effect on the probability of coiled coil formation
(ﬁg. 2B). The Laing myopathy mutations should there-
fore more severely affect the ability of the MYH7 LMM
to make a coiled coil than the mutations associated with
cardiomyopathy (Blair et al. 2002; Richard et al. 2003).
Nevertheless, patients with Laing myopathy usually do
not demonstrate cardiomyopathy (Laing et al. 1995;
Voit et al. 2001; Mastaglia et al. 2002; Hedera et al.
2003). This is a situation similar to the myosin storage
(hyaline body) myopathy caused by mutations in exons
37 and 39 of MYH7, in which cardiac involvement is
minimal (Tajsharghi et al. 2003; Bohlega et al. 2004).
It has been argued that MYH7 mutations produce
either dilated or hypertrophic cardiomyopathy through
effects on different myosin protein interactions (Seid-
man and Seidman 2001; Blair et al. 2002). Two of the
MYH7 Laing myopathy mutations, c.K1617del and
c.K1729del, are caused by loss of one of three consec-
utive lysines, presumably by mechanisms similar to those
that change microsatellite allele size (Xu et al. 2000).
Deletion of a single amino acid residue—one (c.E930del)
in a series of three glutamate residues—in the S2 region
of slow myosin causes cardiomyopathy (Richard et al.
2003). Skeletal muscle disease was not described in these
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Figure 2 COILS analysis of the effect of the four distal-myopathy mutations (A) and seven hypertrophic cardiomyopathy mutations (B)
in the LMM region of MYH7 on the probability of the mutant myosin tails forming a coiled coil. All four distal-myopathy mutations have a
signiﬁcant effect on the probability of the myosin tail forming a coiled coil, whereas the hypertrophic cardiomyopathy mutations have no
signiﬁcant effect on the ability of the myosin tail to form a coiled coil.
patients (Richard et al. 2003). Thus, single amino acid
deletions in the MYH7 rod do not always cause distal
myopathy, suggesting that MYH7 mutations have to lie
within a restricted region to produce the Laingmyopathy
phenotype and probably interrupt a speciﬁc myosin
function.
The mutations causing Laing myopathy may disrupt
the binding of myosin to titin, myomesin, or M-protein.
The titin binding site (Houmeida et al. 1995) corre-
sponds to residues 1815–1831 in slow skeletal myosin
(Jaenicke et al. 1990). Mutations in the M-band region
of titin cause tibial muscular dystrophy (Hackman et al.
2002), which shows a pattern of muscle involvement
similar to Laing myopathy, though it has a later onset
(Mastaglia et al. 2002). The similar distribution of af-
fected muscles might suggest linked pathophysiology.
The M-line proteins M-protein and myomesin have been
shown to bind to the equivalent of residues 1503–1671
in slow skeletal myosin (Obermann et al. 1997, 1998).
Residues 1503–1671 encompass two of the Laing my-
opathy mutations, and the other three are close (ﬁg. 2).
It may be that the MYH7 mutations that cause Laing
myopathy disrupt the binding of myosin to titin, my-
omesin, or M-protein, whereas the mutations in MYH7
that cause cardiomyopathy (Blair et al. 2002; Richard
et al. 2003) or myosin storage myopathy (Tajsharghi et
al. 2003; Bohlega et al. 2004) do not. Linked pathology
in Laing myopathy and tibial muscular dystrophy per-
Reports 707
haps results from interaction ofmutatedmyosin and titin
with myomesin, M-protein, or another component of
the sarcomere.
Rimmed vacuoles and ﬁlamentous inclusions occur in
many distal myopathies, including Laingmyopathy (Voit
et al. 2001), leading to the proposition they are inclu-
sion-body myopathies (Askanas 1997). Therefore, it is
interesting that mutation of fast myosin IIa causes au-
tosomal dominant hereditary inclusion-body myopathy,
IBM3 (Martinsson et al. 2000).
We foundMYH7mutations in six of the seven families
investigated. We did not ﬁnd a mutation in the seventh
family, despite this family showing evidence of linkage
to MYH7. This may reﬂect the already identiﬁed genetic
heterogeneity in early-onset distal myopathy (von Deim-
ling et al. 2001) or that the techniques used to identify
the MYH7 mutations failed to identify the mutation in
the seventh family. MYH7 is the fourth distal-myopathy
gene identiﬁed after dysferlin (Bashir et al. 1998; Liu et
al. 1998), GNE (Kayashima et al. 2002), and titin (Hack-
man et al. 2002; Van den Bergh et al. 2003) and encodes
the second sarcomeric protein shown to be involved.
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